» Authors » Pierre Mordant

Pierre Mordant

Explore the profile of Pierre Mordant including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 132
Citations 1091
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Atchade E, Bunel-Gourdy V, Zappella N, Jean-Baptiste S, Tran-Dinh A, Tanaka S, et al.
Anaesth Crit Care Pain Med . 2025 Feb; :101499. PMID: 39988229
Background: The waitlist deaths of transplantation candidates based on their time on the waiting list (TWL) have already been studied, but the short-term mortality and early complications of lung transplant...
2.
Grall N, Assadi M, Esposito-Farese M, Lortat-Jacob B, Tanaka S, Atchade E, et al.
Transpl Int . 2025 Feb; 37:13545. PMID: 39916770
Secondary prophylaxis using inhaled colistin (IC) was implemented to prevent recurrences of Pseudomonas aeruginosa or extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) pneumonia during the postoperative intensive care unit (ICU) stay after lung...
3.
Bouchez C, Medraoui C, Cazes A, Khalil A, Jebrak G, Mal H, et al.
Respir Med Res . 2024 Dec; 87:101146. PMID: 39689665
Background: Incidental lung cancer, in the field of lung transplantation (LTx), is more often related to malignancies diagnosed in explants or transplanted organs. Little is known about cancer diagnosed during...
4.
Ghanem M, Archer G, Justet A, Jaillet M, Vasarmidi E, Mordant P, et al.
Am J Respir Crit Care Med . 2024 Dec; 211(3):486-498. PMID: 39637324
Idiopathic pulmonary fibrosis (IPF) is a lethal disease with limited therapeutic options. FGF21 (fibroblast growth factor 21), an endocrine fibroblast growth factor that acts through the FGFR1 (fibroblast growth factor...
5.
Ghanem M, Justet A, Jaillet M, Vasarmidi E, Boghanim T, Hachem M, et al.
Am J Physiol Lung Cell Mol Physiol . 2024 Oct; 327(6):L818-L830. PMID: 39350729
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with limited therapeutic options. Fibroblast growth factor receptor-4 (FGFR4) is a known receptor for several paracrine fibroblast growth factors (FGFs). FGFR4...
6.
Avramenko A, Etienne H, Weisenburger G, Mullaert J, Cerceau P, Pellenc Q, et al.
Respir Med Res . 2024 Sep; 86:101139. PMID: 39299136
Introduction: With increasing experience in high-volume centers, age alone should not be an absolute contra-indication to lung transplantation (LT) but be considered as part of the patient's initial characteristics. The...
7.
Blanc T, Capito C, Lambert E, Mordant P, Audenet F, De La Taille A, et al.
J Robot Surg . 2024 Sep; 18(1):332. PMID: 39230755
The number of available hospital beds is decreasing in many countries. Reducing the length of hospital stay (LOS) and increasing bed turnover could improve patient flow. We evaluated whether robot-assisted...
8.
Tanaka S, de Tymowski C, Dupuis E, Tran-Dinh A, Lortat-Jacob B, Harpan A, et al.
Transpl Int . 2024 Jul; 37:12816. PMID: 39015153
Night work is frequently associated with sleep deprivation and is associated with greater surgical and medical complications. Lung transplantation (LT) is carried out both at night and during the day...
9.
Coblence M, Etienne H, Roussel A, Pellenc Q, Cerceau P, Borie R, et al.
J Thorac Dis . 2024 Jul; 16(6):3685-3695. PMID: 38983135
Background: Size matching between donors and recipients is a major issue in lung transplantation (LTx), especially in patients with restrictive lung disease (RLD). This study aims to evaluate computed tomography...
10.
Roussel A, Sage E, Falcoz P, Thomas P, Castier Y, Fadel E, et al.
Thorax . 2024 May; 79(8):745-753. PMID: 38768985
Introduction: Lung graft allocation can be based on a score (Lung Allocation Score) as in the USA or sequential proposals combined with a discrete priority model as in France. We...